ATE421583T1 - Isolierung von nukleinsäuren - Google Patents

Isolierung von nukleinsäuren

Info

Publication number
ATE421583T1
ATE421583T1 AT00929666T AT00929666T ATE421583T1 AT E421583 T1 ATE421583 T1 AT E421583T1 AT 00929666 T AT00929666 T AT 00929666T AT 00929666 T AT00929666 T AT 00929666T AT E421583 T1 ATE421583 T1 AT E421583T1
Authority
AT
Austria
Prior art keywords
substituent
sample
isolation
nucleic acids
rna
Prior art date
Application number
AT00929666T
Other languages
English (en)
Inventor
Andrew Goldsborough
Original Assignee
Cyclops Genome Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9910154.5A external-priority patent/GB9910154D0/en
Priority claimed from GBGB9910158.6A external-priority patent/GB9910158D0/en
Priority claimed from GBGB9910157.8A external-priority patent/GB9910157D0/en
Priority claimed from GBGB9910156.0A external-priority patent/GB9910156D0/en
Application filed by Cyclops Genome Sciences Ltd filed Critical Cyclops Genome Sciences Ltd
Application granted granted Critical
Publication of ATE421583T1 publication Critical patent/ATE421583T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Turbine Rotor Nozzle Sealing (AREA)
  • Window Of Vehicle (AREA)
AT00929666T 1999-04-30 2000-05-02 Isolierung von nukleinsäuren ATE421583T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9910154.5A GB9910154D0 (en) 1999-04-30 1999-04-30 Polynucleotides
GBGB9910158.6A GB9910158D0 (en) 1999-04-30 1999-04-30 Isolation of nucleic acid
GBGB9910157.8A GB9910157D0 (en) 1999-04-30 1999-04-30 Polynucleotides
GBGB9910156.0A GB9910156D0 (en) 1999-04-30 1999-04-30 Polynucleotides

Publications (1)

Publication Number Publication Date
ATE421583T1 true ATE421583T1 (de) 2009-02-15

Family

ID=27451902

Family Applications (2)

Application Number Title Priority Date Filing Date
AT00929665T ATE347616T1 (de) 1999-04-30 2000-05-02 Ribonukleinsäurederivate
AT00929666T ATE421583T1 (de) 1999-04-30 2000-05-02 Isolierung von nukleinsäuren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT00929665T ATE347616T1 (de) 1999-04-30 2000-05-02 Ribonukleinsäurederivate

Country Status (6)

Country Link
US (4) US6794140B1 (de)
EP (2) EP1177281B1 (de)
AT (2) ATE347616T1 (de)
AU (4) AU4767300A (de)
DE (2) DE60032235T2 (de)
WO (4) WO2000066605A2 (de)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1177281B1 (de) 1999-04-30 2009-01-21 Cyclops Genome Sciences Limited Isolierung von nukleinsäuren
US6677120B2 (en) 2001-03-30 2004-01-13 Isis Pharmaceuticals, Inc. Building blocks for the solution phase synthesis of oligonucleotides
CA2474910A1 (en) 2002-02-01 2003-08-07 Sequitur, Inc. Oligonucleotide compositions with enhanced efficiency
US20060009409A1 (en) * 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
US20040072226A1 (en) * 2002-07-03 2004-04-15 Stojanovic Milan N. Movement of multi-enzymatic nanoassemblies on recognition landscapes
US20040005568A1 (en) * 2002-07-03 2004-01-08 Stojanovic Milan N. Movement of multi-enzymatic nanoassemblies on recognition landscapes
GB0217963D0 (en) 2002-08-02 2002-09-11 Cyclops Genome Sciences Ltd Purification of nucleic acids
DE10315581B4 (de) * 2003-04-05 2007-06-28 Agilent Technologies, Inc. (n.d.Ges.d.Staates Delaware), Palo Alto Verfahren zur Qualitätsbestimmung von RNA-Proben
WO2005012522A1 (en) * 2003-07-23 2005-02-10 Cyclops Genome Sciences Limited Clean-up beads
GB0317199D0 (en) 2003-07-23 2003-08-27 Cyclops Genome Sciences Ltd Clean-up beads
DE10344819B4 (de) * 2003-09-26 2017-06-29 Sartorius Stedim Biotech Gmbh Adsorptionsmembranen, Verfahren zur Herstellung derselben und Vorrichtungen, welche die Adsorptionsmembranen umfassen
CA2586532C (en) 2004-11-05 2014-03-25 Qiagen North American Holdings, Inc. Compositions and methods for purifying nucleic acids from stabilization reagents
US20090075342A1 (en) * 2005-04-26 2009-03-19 Sharon Cload Metabolic profile directed aptamer medicinal chemistry
WO2006138145A1 (en) 2005-06-14 2006-12-28 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
US11111544B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US11111543B2 (en) 2005-07-29 2021-09-07 Natera, Inc. System and method for cleaning noisy genetic data and determining chromosome copy number
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US8318424B2 (en) * 2006-06-05 2012-11-27 The University Of North Carolina At Chapel Hill High-throughput RNA structure analysis
US9506056B2 (en) * 2006-06-08 2016-11-29 Northwestern University Nucleic acid functionalized nanoparticles for therapeutic applications
JP5512285B2 (ja) * 2007-02-09 2014-06-04 ノースウェスタン ユニバーシティ 細胞内標的を検出するための粒子
JP2010523078A (ja) * 2007-03-30 2010-07-15 キアゲン ゲゼルシャフト ミット ベシュレンクテル ハフツング リボース環を含む修飾ポリヌクレオチド
US9551033B2 (en) 2007-06-08 2017-01-24 Genentech, Inc. Gene expression markers of tumor resistance to HER2 inhibitor treatment
CN102014919B (zh) 2008-03-03 2015-02-25 托斯克公司 减少毒性的甲氨蝶呤佐剂及其使用方法
WO2009150156A1 (en) * 2008-06-13 2009-12-17 Riboxx Gmbh Method for enzymatic synthesis of chemically modified rna
AU2009316286B2 (en) 2008-11-24 2016-05-26 Northwestern University Polyvalent RNA-nanoparticle compositions
US20100233270A1 (en) * 2009-01-08 2010-09-16 Northwestern University Delivery of Oligonucleotide-Functionalized Nanoparticles
SG2014011381A (en) 2009-02-13 2014-06-27 Chem Inc X Methods of creating and screening dna-encoded libraries
EP2272976A1 (de) * 2009-07-06 2011-01-12 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Differenzierung von Polynucleotid-Strängen
EP2854056A3 (de) 2009-09-30 2015-06-03 Natera, Inc. Verfahren zur nichtinvasiven pränatalen Ploidiezuordnung
WO2011053940A2 (en) 2009-10-30 2011-05-05 Northwestern University Templated nanoconjugates
EP2333102A1 (de) * 2009-12-14 2011-06-15 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Identifizierung von RNA-Liganden
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2572003A4 (de) 2010-05-18 2016-01-13 Natera Inc Verfahren zur nichtinvasiven pränatalen ploidiezuordnung
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
EP2388324A1 (de) 2010-05-20 2011-11-23 Siemens Healthcare Diagnostics Inc. Kontrollmaterial für Nukleinsäureteste
FR2968302B1 (fr) 2010-12-06 2012-11-30 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
JP6328934B2 (ja) 2010-12-22 2018-05-23 ナテラ， インコーポレイテッド 非侵襲性出生前親子鑑定法
BR112013020220B1 (pt) 2011-02-09 2020-03-17 Natera, Inc. Método para determinar o estado de ploidia de um cromossomo em um feto em gestação
EP3351631B1 (de) * 2011-09-07 2020-11-04 X-Chem, Inc. Verfahren zur markierung dna-codierter bibliotheken
CN104023749B (zh) 2011-09-14 2019-12-17 西北大学 能穿过血脑屏障的纳米缀合物
US9480966B2 (en) 2012-04-30 2016-11-01 General Electric Company Substrates and methods for collection, stabilization and elution of biomolecules
US9040675B2 (en) 2012-04-30 2015-05-26 General Electric Company Formulations for nucleic acid stabilization on solid substrates
US9044738B2 (en) 2012-04-30 2015-06-02 General Electric Company Methods and compositions for extraction and storage of nucleic acids
US9040679B2 (en) 2012-04-30 2015-05-26 General Electric Company Methods and compositions for extraction and storage of nucleic acids
ES2855137T3 (es) 2012-07-13 2021-09-23 X Chem Inc Bibliotecas codificadas por ADN que tienen vínculos de oligonucleótidos codificadores que no se pueden leer por polimerasas
FR2994184B1 (fr) 2012-08-02 2017-12-08 Biomerieux Sa Procedes de fonctionalisation et reactifs utilises dans de tels procedes utilisant un anhydride aza-isatoique ou un de ses derives, molecules biologiques ainsi traitees et kits
WO2014093688A1 (en) * 2012-12-12 2014-06-19 1Massachusetts Institute Of Technology Compositions and methods for functional nucleic acid delivery
US10577655B2 (en) 2013-09-27 2020-03-03 Natera, Inc. Cell free DNA diagnostic testing standards
US10240188B2 (en) 2013-10-07 2019-03-26 The University Of North Carolina At Chapel Hill Detection of chemical modifications in nucleic acids
EP3134541B1 (de) 2014-04-21 2020-08-19 Natera, Inc. Nachweis von ploidien in chromosomalen segmenten in krebs
WO2015164773A1 (en) 2014-04-25 2015-10-29 Shire Human Genetic Therapies, Inc. Methods for purification of messenger rna
CN107405540A (zh) * 2014-10-24 2017-11-28 雅培分子公司 小核酸的富集
CN107106493A (zh) 2014-11-21 2017-08-29 西北大学 球形核酸纳米颗粒缀合物的序列特异性细胞摄取
DK3294885T3 (da) 2015-05-08 2020-08-10 Curevac Real Estate Gmbh Fremgangsmåde til at fremstille rna
WO2016183106A1 (en) 2015-05-11 2016-11-17 Natera, Inc. Methods and compositions for determining ploidy
WO2016193206A1 (en) 2015-05-29 2016-12-08 Curevac Ag A method for producing and purifying rna, comprising at least one step of tangential flow filtration
BR112017026193B1 (pt) 2015-06-05 2021-09-14 W.R. Grace & Co-Conn Adsorventes, método de produção dos adsorventes e uso dos adsorventes
EP4035762B1 (de) 2015-09-09 2023-11-01 Drawbridge Health, Inc. Vorrichtungen zur probeentnahme, stabilisierung und konservierung
US10214739B2 (en) * 2015-10-30 2019-02-26 Axagarius Gmbh & Co. Kg RNA binding solution
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
JP7094949B2 (ja) 2016-11-07 2022-07-04 ナノスール エルエルシー 転写後化学修飾二重鎖ｒｎａ
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CN110234277B (zh) 2017-01-10 2022-07-05 集联健康有限公司 用于样品收集的装置、系统和方法
US10894976B2 (en) * 2017-02-21 2021-01-19 Natera, Inc. Compositions, methods, and kits for isolating nucleic acids
US11053608B2 (en) * 2017-06-16 2021-07-06 Boris Farber Combinatorial derivatives of RNA oligonucleotides
IL297543A (en) 2017-11-30 2022-12-01 Arrakis Therapeutics Inc Nucleic acid-binding photoprobes and their uses
WO2019118926A1 (en) 2017-12-14 2019-06-20 Tai Diagnostics, Inc. Assessing graft suitability for transplantation
FR3078977B1 (fr) * 2018-03-16 2023-03-17 Biomerieux Sa Procede d'extraction d'acides nucleiques
WO2019200228A1 (en) 2018-04-14 2019-10-17 Natera, Inc. Methods for cancer detection and monitoring by means of personalized detection of circulating tumor dna
US11525159B2 (en) 2018-07-03 2022-12-13 Natera, Inc. Methods for detection of donor-derived cell-free DNA
CA3228823A1 (en) * 2021-08-31 2023-03-09 Darren H. Wakefield High molecular weight modified dsrna compositions
WO2023101963A2 (en) * 2021-11-30 2023-06-08 Northwestern University Compositions for inhibiting dipeptide repeat protein-ribosomal rna interaction and uses thereof
WO2024167836A1 (en) * 2023-02-06 2024-08-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and modifications for reducing innate immune responses to rna

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588718A (en) * 1984-03-28 1986-05-13 The Upjohn Company Carboxy containing ester prodrugs of corticosteroids
US5681726A (en) * 1988-09-19 1997-10-28 Stratagene Method of double stranded DNA synthesis
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US5660985A (en) * 1990-06-11 1997-08-26 Nexstar Pharmaceuticals, Inc. High affinity nucleic acid ligands containing modified nucleotides
US5707796A (en) 1990-06-11 1998-01-13 Nexstar Pharmaceuticals, Inc. Method for selecting nucleic acids on the basis of structure
DE69133511T2 (de) * 1990-08-13 2006-09-28 Isis Pharmaceuticals, Inc., Carlsbad Zuckermodifizierte oligonukleotide zum erkennen und steuern der genexpression
US5426180A (en) * 1991-03-27 1995-06-20 Research Corporation Technologies, Inc. Methods of making single-stranded circular oligonucleotides
US6235887B1 (en) * 1991-11-26 2001-05-22 Isis Pharmaceuticals, Inc. Enhanced triple-helix and double-helix formation directed by oligonucleotides containing modified pyrimidines
CA2156394A1 (en) 1993-02-24 1994-09-01 Jui H. Wang Compositions and methods of application of reactive antiviral polymers
CA2174339A1 (en) * 1993-10-27 1995-05-04 Lech W. Dudycz 2'-amido and 2'-peptido modified oligonucleotides
US5700642A (en) * 1995-05-22 1997-12-23 Sri International Oligonucleotide sizing using immobilized cleavable primers
CA2261892A1 (en) * 1996-07-24 1998-01-29 Michelle M. Hanna Base-protected nucleotide analogs with protected thiol groups
US5849902A (en) * 1996-09-26 1998-12-15 Oligos Etc. Inc. Three component chimeric antisense oligonucleotides
EP2292771A3 (de) * 1997-09-19 2011-07-27 Life Technologies Corporation Sense mRNA Therapie
DE19801153A1 (de) * 1998-01-14 1999-07-15 Jenne Andreas Verfahren zur Selektion von Ribozymen, die Ribonucleinsäuren in trans an 2'-OH-Gruppen kovalent modifizieren können und durch dieses Verfahren erhältliche Ribozyme
AU751480B2 (en) * 1998-04-29 2002-08-15 Ribozyme Pharmaceuticals, Inc. Nucleoside triphosphates and their incorporation into ribozymes
ATE251181T1 (de) 1998-07-28 2003-10-15 Micromet Ag Heterominikörper
EP1177281B1 (de) * 1999-04-30 2009-01-21 Cyclops Genome Sciences Limited Isolierung von nukleinsäuren
US6720144B1 (en) * 2001-06-21 2004-04-13 Quest Diagnostics Detection of clonal T-cell receptor-γ gene rearrangement by PCR/temporal temperature gradient gel electrophoresis (TTGE)
GB0217963D0 (en) 2002-08-02 2002-09-11 Cyclops Genome Sciences Ltd Purification of nucleic acids
WO2005012522A1 (en) 2003-07-23 2005-02-10 Cyclops Genome Sciences Limited Clean-up beads

Also Published As

Publication number Publication date
EP1177281A2 (de) 2002-02-06
US7244568B2 (en) 2007-07-17
EP1196631B1 (de) 2006-12-06
AU4767300A (en) 2001-12-17
AU4589000A (en) 2000-11-17
ATE347616T1 (de) 2006-12-15
WO2001094626A1 (en) 2001-12-13
AU4767400A (en) 2000-12-28
WO2000075302A2 (en) 2000-12-14
EP1196631A1 (de) 2002-04-17
US20050074753A1 (en) 2005-04-07
EP1177281B1 (de) 2009-01-21
AU4588000A (en) 2000-12-28
DE60032235D1 (de) 2007-01-18
WO2000066605A2 (en) 2000-11-09
US20030039985A1 (en) 2003-02-27
WO2000075306A2 (en) 2000-12-14
US6867290B2 (en) 2005-03-15
US6794140B1 (en) 2004-09-21
US20050272679A1 (en) 2005-12-08
WO2000075302A3 (en) 2001-04-26
WO2000066605A3 (en) 2001-04-26
DE60041442D1 (de) 2009-03-12
DE60032235T2 (de) 2007-11-15
WO2000075306A3 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
ATE421583T1 (de) Isolierung von nukleinsäuren
KR920701478A (ko) 핵산서열의 증폭방법
EP1068356B8 (de) Adressierbare protein arrays
ES2195171T3 (es) Sistema de transposicion in vitro usando transposasa tn5 modificada.
KR100204360B1 (en) A method for identifying a polynucleotide molecule having a selected nucleic acid sequence from a library of random or semi-random polynucleotide molecules
ATE426045T1 (de) Prozess zur synthetisierung von nukleinsaure
SE8800864D0 (sv) Method of assaying of nucleic acids, a reagent combination and kit therefore
ATE144290T1 (de) Amplifikationsverfahren
DK0923598T3 (da) Fremstilling og anvendelse af normaliserede DNA-biblioteker
CA2230967A1 (en) Improved nucleic acid assays
DE69731939D1 (de) Isolierung von einzelsträngigen nukleinsäuren
FI883722A0 (fi) Alfa-amiderande enzymkompositioner och foerfaranden foer deras framstaellning och anvaendning.
WO2000053804A3 (en) Genetic screening
DE50213370D1 (de) Mikrofluidisches extraktionsverfahren
EP0293079A3 (de) Chlamydia-Vakzin
SE8602416D0 (sv) Gen for ligninnedbrytning och anvendning derav
ATE366302T1 (de) Ein polynucleotidmotor, ein motorsystem, seine herstellung und verwendungen
PL146824B1 (en) Method of obtaining 4-sulfanilamido-2,6-dimetoxypyrimidine
WO1997037040A3 (en) Isolation and/or amplification of hepatitis c virus (hcv) nucleic acids from samples suspected to contain hcv
ES2090312T3 (es) Segmentos de adn y microorganismos transformados que comprenden el gen de la delta-1-deshidrogenasa, y sus aplicaciones.
JPS5589274A (en) Coriloxin and its preparation
MX9708943A (es) Genes de polifenol oxidasa de la lengua y platano.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties